Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume 26, Issue 5, Pages 827-829Publisher
WILEY
DOI: 10.1111/ene.13785
Keywords
age of onset; human genetics; modifiers; Parkinson's disease
Categories
Funding
- National Medical Research Council under the Singapore Translational Research Investigator Award (STaR) award [NMRC/STaR/014/2013]
- National Medical Research Council under Translational and Clinical Research Flagship Programme in Parkinson's disease [NMRC/TCR/013-NNI/2014]
- Agency for Science, Technology and Research
- Duke-NUS Graduate Medical School
- Singapore Millennium Foundation
Ask authors/readers for more resources
Background and purpose Genetic variability in DNM3 has been shown to modify age of onset of Parkinson's disease (PD) among LRRK2 Gly2019Ser carriers in North African Arab-Berber populations. In Asian populations, the Gly2019Ser mutation is rare or absent but two other LRRK2 variants, Gly2385Arg and Arg1628PPro, increase PD risk. We aimed to determine whether the DNM3 locus was associated with age of PD onset in both carriers and non-carriers of LRRK2 risk variants in Asians. Methods We analyzed the association of DNM3 rs2421947 genotypes with age of PD onset in 3645 Chinese samples, of which 369 carried at least one of two Asian LRRK2 risk variants. Results DNM3 rs2421947 genotypes were not associated with age of PD onset in Chinese samples. We observed no heterogeneity in the effect of rs2421947 between the Asian LRRK2 risk variant carriers and non-carriers. Conclusions DNM3 rs2421947 was not associated with age of PD onset in LRRK2 risk variant carriers and non-carriers in Chinese samples. Further studies in other Asian populations will be of interest.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available